Ozempic Dosage Chart and Titration Schedule: A 2026 Guide

A clear Ozempic dosage chart for 2026: how the 0.25 mg starter dose steps up to 0.5 mg, 1 mg, and a 2 mg maximum, why titration is slow, and how Ozempic dosing differs from Wegovy.

Majesta Health Medical TeamMedically Reviewed
Reviewed Jun 29, 202610 min read

Quick Answer

The standard Ozempic titration starts at 0.25 mg once weekly for weeks 1 through 4 as a starter and tolerability dose, then moves to 0.5 mg weekly for weeks 5 through 8. From there a clinician may increase to 1 mg weekly, with a maximum of 2 mg once weekly. Ozempic is FDA-approved for type 2 diabetes. Wegovy is the same molecule (semaglutide) approved for weight management at a higher 2.4 mg maximum. A licensed clinician sets and adjusts your dose. Results may vary.

Ozempic dosage chart (weekly injection)

Ozempic is a once-weekly semaglutide injection. The schedule below reflects the labeled titration used in the SUSTAIN clinical trial program, the evidence base that supported FDA approval for type 2 diabetes. These are medication and trial figures, not personal outcomes.

Dose (once weekly)Typical timingPurpose
0.25 mgWeeks 1 to 4Starter and tolerability dose. Not intended for blood sugar control, it helps the body adjust.
0.5 mgWeeks 5 to 8First therapeutic maintenance dose for glycemic control.
1 mgWeek 9 and beyond, if neededHigher maintenance dose when additional control is needed.
2 mgAfter at least 4 weeks at 1 mg, if neededMaximum approved weekly dose.

Each step generally lasts at least 4 weeks before any increase. Your clinician may keep you at a lower maintenance dose if it works well for you, so not everyone reaches 1 mg or 2 mg.

Important: Ozempic vs Wegovy dosing

This is the part that confuses many people. Ozempic and Wegovy are the same drug, semaglutide, but they are approved for different purposes at different maximum doses.

  • Ozempic is FDA-approved for type 2 diabetes. Maximum dose: 2 mg once weekly.
  • Wegovy is FDA-approved for chronic weight management. Maximum dose: 2.4 mg once weekly.
  • Because the indications differ, the pen strengths and the titration steps are not identical. Using Ozempic specifically for weight loss is off-label, which means a prescriber is using an approved drug for a use outside its labeled indication. That decision belongs to a licensed clinician. For a deeper comparison, see our guide on Ozempic vs Wegovy.

    Why titration is slow

    The stepwise schedule is not arbitrary. Semaglutide commonly causes gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation, especially when starting or increasing the dose. Stepping up roughly every 4 weeks gives the digestive system time to adapt, which can reduce the intensity of these effects.

    This is why the 0.25 mg starting dose exists. It is too low to provide meaningful blood sugar control on its own, and its only job is to help your body get used to the medication before reaching a therapeutic dose. Rushing the schedule tends to increase side effects without adding benefit.

    Compounded semaglutide and the start-low principle

    Some patients receive compounded semaglutide rather than a brand-name pen. Compounded semaglutide contains the same active molecule, so clinicians often follow the same start-low, go-slow logic: begin at a low weekly dose, hold for several weeks, then adjust only with clinical guidance.

    A few points matter here. Compounded medications are not FDA-approved as final products. Dosing for compounded semaglutide is determined individually by the prescribing clinician and may be expressed differently than the brand pen strengths. Because of this, you should never assume a compounded schedule matches the brand chart exactly. For more detail on the broader semaglutide schedule, see our semaglutide dosage chart and titration schedule. Results may vary.

    What to do if you miss a dose

    Ozempic is designed for once-weekly use, so timing matters but there is some flexibility.

  • If you remember within 5 days of the missed dose, you can usually take it as soon as you remember, then resume your normal weekly schedule.
  • If more than 5 days have passed, skip the missed dose entirely and take your next dose on your regular day.
  • After a longer gap (for example, several weeks without a dose), your tolerance may drop. A clinician may want to restart titration at a lower dose to limit side effects.
  • Whenever you are unsure, confirm the right next step with your prescriber rather than guessing.

    How a clinician personalizes your schedule

    The chart above is a general framework, not a fixed prescription. A clinician weighs your blood sugar response, how well you tolerate each dose, other medications you take, and your overall health before moving to the next step. Some people stay at 0.5 mg or 1 mg long term. Others move toward the 2 mg maximum. The right schedule is the one a licensed provider sets for you, and it can change over time.

    The bottom line

    The Ozempic dosage chart follows a predictable shape: 0.25 mg to start, 0.5 mg as the first maintenance dose, then 1 mg and up to a 2 mg weekly maximum, with about 4 weeks between steps. Ozempic is approved for type 2 diabetes, while Wegovy delivers the same semaglutide molecule at a higher 2.4 mg maximum for weight management. Compounded semaglutide uses the same start-low principle but is not FDA-approved as a final product and is dosed individually. Whatever path applies to you, the dose should be set and adjusted by a licensed clinician. Results may vary.

    This article is for educational purposes only and is not medical advice. It does not replace consultation with a licensed healthcare provider. Talk with a qualified clinician before starting, changing, or stopping any medication.

    Frequently Asked Questions

    What is the standard Ozempic dosage chart?

    Ozempic is typically started at 0.25 mg once weekly for the first 4 weeks as a tolerability dose, increased to 0.5 mg weekly for weeks 5 through 8, then raised to 1 mg weekly if more blood sugar control is needed. The maximum approved dose is 2 mg once weekly. A licensed clinician decides each step based on response and side effects, so individual schedules vary.

    How do I increase my Ozempic dose safely?

    Dose increases are guided by a prescriber and usually happen after at least 4 weeks at the current dose. The slow, stepwise approach gives your digestive system time to adjust and helps limit nausea and other gastrointestinal effects. Never raise your dose on your own. Talk with your clinician before any change.

    Is Ozempic dosing the same as Wegovy dosing?

    No. Ozempic and Wegovy are both semaglutide, but they are approved for different uses at different maximum doses. Ozempic is FDA-approved for type 2 diabetes with a 2 mg weekly maximum, while Wegovy is approved for chronic weight management at a 2.4 mg weekly maximum. The titration steps and pen strengths differ.

    What should I do if I miss a dose of Ozempic?

    Ozempic is taken once weekly. If you remember within 5 days of the missed dose, you can usually take it as soon as you remember. If more than 5 days have passed, skip the missed dose and take your next dose on the regular day. After a long gap, your clinician may want to restart titration. Always confirm the right step with your prescriber.

    Does compounded semaglutide follow the same dosing curve?

    Compounded semaglutide contains the same active molecule, so clinicians often apply the same start-low, go-slow principle. However, compounded medications are not FDA-approved as final products, and dosing is set individually by the prescribing clinician. Results may vary, and your schedule should always be confirmed with your provider.

    Medically reviewed

    Majesta Health Medical Team

    Clinical Editorial Team

    All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.

    Credentials and accreditation
    • US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
    • Board-certified in primary care and obesity medicine
    • Active state medical licensure required for every prescribing clinician
    • Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
    • Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
    • Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)
    Areas of expertise
    GLP-1 receptor agonist therapy (semaglutide, tirzepatide, liraglutide)Chronic weight managementObesity medicineCompounded medication clinical oversightTelehealth informed consent and patient screening
    Have a question for our medical team? See our full clinical team page or contact support.

    Ready to Reserve Your Spot?

    Join the founding-member waitlist for priority access and locked-in pricing.

    Start Your Assessment